MICALLEF JACOB VINCENT (Chief Scientific Officer) purchased 59.1% of their position (13K shares) of VOLITIONRX LTD on the open market
Open‑market purchase worth $22.1K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/20/2022ACC: 0001477932-22-007051
Officer· Chief Scientific Officer
+13K
Net shares
Net buyer
$22.1K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
13K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+13K
Price / share
$1.70
Trade value
$22.10K
% of position
59.1%
—
22K→35K
Total
Net shares
+13K
Net value
$22.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | — | P · Purchase | +13K | $1.70 | $22.10K | 59.1% | 22K | 35K |
| Total | +13K | $22.10K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned38.11K
Common Stock
DirectShares owned149.23K
Total
149.23K direct·38.11K indirect187.34K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 38.11K | Indirect |
| Common Stock | 149.23K | Direct |
| Total | 187.34K | 149.23K direct·38.11K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported